Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-10-09
2007-10-09
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235500, C514S318000, C514S340000, C514S341000, C514S342000, C514S343000, C514S357000, C514S253010, C544S060000, C544S124000, C544S360000, C546S272700, C546S275400, C546S279100, C546S276400, C546S280400, C546S193000, C546S292000
Reexamination Certificate
active
10319885
ABSTRACT:
Use of compounds to inhibit hormone-sensitive lipase, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitive lipase and may be useful in the treatment and/or prevention of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.
REFERENCES:
patent: 2449440 (1948-09-01), Aeschlimann
patent: 4016278 (1977-04-01), Koch et al.
patent: 4081461 (1978-03-01), Fex et al.
patent: 5463062 (1995-10-01), Hemmerle et al.
patent: 5721236 (1998-02-01), Bishop et al.
patent: 5780472 (1998-07-01), Cho et al.
patent: 5837727 (1998-11-01), Bauer et al.
patent: 5866565 (1999-02-01), Shutske et al.
patent: 665273 (1965-10-01), None
patent: 2336526 (1975-02-01), None
patent: 2801187 (1978-07-01), None
patent: 4324060 (1995-01-01), None
patent: 0587311 (1993-08-01), None
patent: 1201649 (2001-10-01), None
patent: 982235 (1965-02-01), None
patent: 1307923 (1973-02-01), None
patent: WO97/01533 (1997-01-01), None
patent: 10087485 (1998-04-01), None
patent: 92/06075 (1992-04-01), None
patent: 92/07838 (1992-05-01), None
patent: 95/29155 (1995-11-01), None
patent: WO96/02524 (1996-02-01), None
patent: 97/01533 (1997-01-01), None
patent: WO98/53814 (1998-12-01), None
patent: WO99/62870 (1999-12-01), None
patent: WO 00/54759 (2000-09-01), None
patent: WO 00/54759 (2000-09-01), None
patent: WO 00/59510 (2000-10-01), None
patent: WO 00/63208 (2000-10-01), None
patent: WO 00/69810 (2000-11-01), None
patent: 01/21602 (2001-03-01), None
patent: WO 01/21584 (2001-03-01), None
patent: WO 01/47923 (2001-07-01), None
patent: WO 01/87843 (2001-11-01), None
patent: WO 02/006189 (2002-01-01), None
patent: WO 02/006189 (2002-01-01), None
patent: 02/12210 (2002-02-01), None
patent: WO 02/20483 (2002-03-01), None
patent: 02/42257 (2002-05-01), None
patent: WO 02/38153 (2002-05-01), None
patent: 03/051841 (2003-06-01), None
patent: 03/051842 (2003-06-01), None
Angier et al. (J. Med. Chem. (1968), 11(4), 720-9).
Hansen et al., International Journal of Pharmaceutics, vol. 79, pp. 205-212 (1992).
Schmidt et al., Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 8, pp. 1071-1076 (1997).
Wheatley W.B. et al., Benzylphenol Derivatives (1957) vol. 79, pp. 747-749.
Niculescu-Duvaz, I et al. Neoplasma, (1966), vol. 13, pp. 583-589.
Niculescu-Duvaz, I et al., Canadian Journal of Chemistry, (1966), vol. 44, pp. 1102-1105.
Niculescu-Duvaz, I et al., (1967) vol. 18, Part 5, pp. 296-299.
Abstract of DE 2801187.
Abstract of DE 2336526.
Abstract of BE 665273.
de Jong Johannes Cornelis
Ebdrup Soren
Hansen Holger Claus
Jacobsen Poul
Vedso Per
Habte Kahsay
Novo Nordisk A S
Wilk-Oresean Rosemarie
LandOfFree
Compounds and uses thereof for decreasing activity of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and uses thereof for decreasing activity of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and uses thereof for decreasing activity of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3851925